Acute Hepatic Porphyria (APH) Market

Acute Hepatic Porphyria (APH) Market Forecast, By indication(Acute intermittent Porphyria (AIP) , Variagate Porphyria (VP) , Hereditary Coproporphyria (HC) , Hereditary Deficit of Delta-aminolevulinic Acid Dehydratase (HDAD))- Global Market Insights 2019 to 2029

Analysis of Acute Hepatic Porphyria (APH) market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Free Sample

Introduction

Porphyria is aninborn error of heme biosynthesis, classified into 8 genetically distinct metabolic disorders.Heme is a component of hemoglobin, the oxygen carrier protein in the blood.Acute hepatic porphyria (APH) is one of the rare and significantly females dominated subtype of porphyrias, primarily affect the nervous system.

In the United States, the prevalence of porphyria is approximated to be 1 in 25,000 individuals and the prevalence of clinical APHis reported to be 5 to 10 per 100,000 individuals.Drug therapies used to treatacute hepatic porphyria (APH) includes intravenous hemin, nutrition and hydration supplement, and anti-epileptic drugs. For life-threatening acute attacks liver transplantation may be required.

Acute Hepatic Porphyria (APH)Market: Drivers and Restraints

Advancements in diagnosis of metabolic disorders is primarily expected to grow the global acute hepatic porphyria (APH) market. Government initiative and research funding to meet the unmet market demand is expected to grow the global acute hepatic porphyria (APH) market.

In addition, favorable regulations and approval support from regulatory authorities is expected to drive industry players to launch novel therapeutics in the market. This trend is expected to grow the acute hepatic porphyria (APH) market. However, low awareness and poor access to healthcare in emerging regions are expected to hamper the growth of acute hepatic porphyria (APH) market.

Acute Hepatic Porphyria (APH)Market: Overview

The acute hepatic porphyria (APH) market is expected to experience moderate growth over the forecast period owing to higher government initiative to develop innovative therapeutics for acute hepatic porphyria (APH).Byindication, acute intermittent porphyria (AIP)segment is expected to hold the major market share in the acute hepatic porphyria (APH) market. Among drug class, intravenous heminsegment is expected to hold the major market share in the acute hepatic porphyria (APH) market.

Recently, in the end of 2019, FDA has approvedGIVLAARI® (givosiran injections)first and only one treatment for acute hepatic porphyria (APH)manufactured by the Alnylam Pharmaceuticals, Inc. Among distribution channels, retail pharmacies segment is expected to be the leading revenue generating segment in acute hepatic porphyria (APH) market owing to higher patient footfall.

Acute Hepatic Porphyria (APH)Market: Regional Outlook

Geographically, global acute hepatic porphyria (APH)market is segmented into seven key regions viz. North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa. North America is prominent region in acute hepatic porphyria (APH)market owing to new treatment launches.

European acute hepatic porphyria (APH)market is a second most lucrative region due to early diagnosis and government support. In addition, East Asia region substantially has higher market growth rate owing tohigher population base. Middle East and Africa is expected to be least-lucrative market owing to hightreatment cost barrier and poor healthcare infrastructure.

Acute Hepatic porphyria (APH)Market: Key Players

The global market for acute hepatic porphyria (APH)is consolidated withlarge number of market players. Examples of some of the primary key players operating in the global acute hepatic porphyria (APH)market are Recordati Rare Diseases Inc., Lundbeck Inc., andAlnylam Pharmaceuticals, Inc.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers an exhaustive analysis on:

Acute Hepatic Porphyria (APH)Market Segments
Acute Hepatic Porphyria (APH)Market Dynamics
Acute Hepatic Porphyria (APH)Market Size
Acute Hepatic Porphyria (APH)Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, and Rest of Latin America)
Europe (Germany, Italy, U.K, Spain, France, Russia and Rest of Europe)
South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)
East Asia (China, South Korea, Japan)
Oceania (Australia, New Zealand)
Middle East and Africa (GCC, S. Africa, Turkey, andRest Of MEA)

Report Highlights:

A detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Acute Hepatic Porphyria (APH)Market: Segmentation

The acute hepatic porphyria (APH)market can besegmented into indication, drug type, distribution channels and geography.

Based on indication, the global acute hepatic porphyria (APH)market is segmented as:

Acute intermittent Porphyria (AIP)
Variagate Porphyria (VP)
Hereditary Coproporphyria (HC)
Hereditary Deficit of Delta-aminolevulinic Acid Dehydratase (HDAD)

Based on drug type, the global acute hepatic porphyria (APH)market is segmented as:

Intravenous Hemin
Carbohydrate Nutrition and Hydration
Hypertonic Saline
Anti-epileptics (Short-acting)

Based on the distribution channels, the global acute hepatic porphyria (APH)market is segmented as:

Hospital Pharmacies
Drug Stores
Retail Pharmacies
Online Pharmacies

Table of Content

Executive Summary - Acute Hepatic Porphyria (APH) Market
- Global Market Outlook
- Demand-side Trends
- Supply-side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Inclusion and Exclusion
Value Added Insights
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
  - Supply Side Participants and their Roles
    - Producers
    - Mid-Level Participants (Traders/ Agents/ Brokers)
    - Wholesalers and Distributors
  - Value Added and Value Created at Node in the Supply Chain
  - List of Raw Material Suppliers
  - List of Existing and Potential Buyers
- Pricing Analysis of Acute Hepatic Porphyria (APH) Market
  - Pricing Analysis By Region
  - Pricing Analysis By Country
  - Pricing Analysis By End Use
  - Pricing Analysis By Distributor
  - Pricing Analysis By Application
- Value Chain Analysis
  - Profit Margin Analysis
  - Wholesalers and Distributors
  - Retailers
- Product Portfolio Analysis
- Regulatory Landscape
  - By Key Regions
  - By Key Countries
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Investment Feasibility Matrix
- PESTLE Analysis
  - Political Factors
    - Government stability and change
    - Taxation policy and incentives
    - Trade tariffs and import/export regulations
    - Political risk and corruption levels
  - Economic Factors
    - GDP growth and economic cycles
    - Inflation and interest rates
    - Exchange rate fluctuations
    - Unemployment and consumer spending power
  - Social Factors
    - Demographic trends (age, population growth)
    - Cultural attitudes and lifestyle changes
    - Education levels and workforce skills
    - Health consciousness and social values
  - Technological Factors
    - Rate of technological innovation
    - R&D activity and automation trends
    - Digital infrastructure and connectivity
    - Intellectual property protection
  - Legal Factors
    - Employment and labor laws
    - Health & safety regulations
    - Consumer protection laws
    - Data privacy and antitrust legislation
  - Environmental Factors
    - Environmental regulations and compliance
    - Climate change impacts and carbon footprint
    - Resource availability and sustainability practices
    - Waste management and recycling initiatives
- Market Background and Dynamics
  - Market Dynamics
    - Drivers
    - Restraints
    - Opportunity
    - Trends
  - SWOT Analysis of Global Acute Hepatic Porphyria (APH) Market
    - Strengths
    - Weaknesses
    - Opportunities
    - Threats
Global Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast, 2025-2035
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Projections, 2025-2035
  - Y-o-Y Growth Trend Analysis
  - Absolute $ Opportunity Analysis
- Revenue Forecast Scenario, 2020-2035
  - Conservative Scenario
  - Likely Scenario
  - Optimistic Scenario
Global Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast 2025-2035, By Application
- Introduction / Key Findings
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis By Application, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By Application, 2025-2035
- Y-o-Y Growth Trend Analysis By Application, 2020-2024
- Absolute $ Opportunity Analysis By Application, 2025-2035
- Market Attractiveness Analysis By Application, 2025-2035
Global Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast 2025-2035, By End Use
- Introduction / Key Findings
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis By End Use, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By End Use, 2025-2035
- Y-o-Y Growth Trend Analysis By End Use, 2020-2024
- Absolute $ Opportunity Analysis By End Use, 2025-2035
- Market Attractiveness Analysis By End Use, 2025-2035
Global Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast 2025-2035, By Region
- Introduction
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis By Region, 2020-2024
- Current Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By Region, 2025-2035
  - North America
  - Latin America
  - Western Europe
  - Eastern Europe
  - East Asia
  - South Asia and Pacific & Pacific
  - MEA
- Market Attractiveness Analysis By Region
North America Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast 2025-2035
- Introduction
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2025-2035
- By Country
  - USA
  - Canada
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - USA Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Canada Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Mexico Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Latin America Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Brazil
  - Argentina
  - Chile
  - Rest of Latin America
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Brazil Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Argentina Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Chile Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of Latin America Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Western Europe Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Germany
  - UK
  - Italy
  - Spain
  - France
  - Nordic
  - BENELUX
  - Rest of Western Europe
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Germany Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - UK Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Italy Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Spain Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - France Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Nordic Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - BENELUX Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of Western Europe Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Eastern Europe Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Russia
  - Poland
  - Hungary
  - Balkan & Baltic
  - Rest of Eastern Europe
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Russia Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Poland Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Hungary Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Balkan & Baltic Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of Eastern Europe Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
East Asia Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - China
  - Japan
  - South Korea
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - China Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Japan Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - South Korea Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
South Asia and Pacific Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - India
  - ASEAN
  - Australia & New Zealand
  - Rest of South Asia and Pacific
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - India Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - ASEAN Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Australia & New Zealand Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of South Asia and Pacific Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
MEA Acute Hepatic Porphyria (APH) Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Kingdom of Saudi Arabia
  - Other GCC Countries
  - Turkiye
  - South Africa
  - Other African Union
  - Rest of Middle East & Africa
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Kingdom of Saudi Arabia Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Other GCC Countries Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Turkiye Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - South Africa Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - South Africa Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of MEA Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of MEA Acute Hepatic Porphyria (APH) Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
  - By Region
  - By Application
  - By End Use
- Competition Analysis
- Competition Deep Dive
  - Global Key Players
  - Key Players by Region
  - Key Players by Country
Assumptions & Acronyms Used
Research Methodology

List Of Table

Table 1: Global Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Region, 2020-2035
Table 2: Global Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Region, 2020-2035
Table 3: Global Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 4: Global Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Application, 2020-2035
Table 5: Global Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 6: Global Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by End Use, 2020-2035
Table 7: North America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 8: North America Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Country, 2020-2035
Table 9: North America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 10: North America Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Application, 2020-2035
Table 11: North America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 12: North America Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by End Use, 2020-2035
Table 13: Latin America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 14: Latin America Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Country, 2020-2035
Table 15: Latin America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 16: Latin America Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Application, 2020-2035
Table 17: Latin America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 18: Latin America Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by End Use, 2020-2035
Table 19: Europe Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 20: Europe Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Country, 2020-2035
Table 21: Europe Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 22: Europe Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Application, 2020-2035
Table 23: Europe Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 24: Europe Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by End Use, 2020-2035
Table 25: East Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 26: East Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Country, 2020-2035
Table 27: East Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 28: East Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Application, 2020-2035
Table 29: East Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 30: East Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by End Use, 2020-2035
Table 31: South Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 32: South Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Country, 2020-2035
Table 33: South Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 34: South Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Application, 2020-2035
Table 35: South Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 36: South Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by End Use, 2020-2035
Table 37: Oceania Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 38: Oceania Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Country, 2020-2035
Table 39: Oceania Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 40: Oceania Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Application, 2020-2035
Table 41: Oceania Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 42: Oceania Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by End Use, 2020-2035
Table 43: MEA Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 44: MEA Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Country, 2020-2035
Table 45: MEA Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 46: MEA Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by Application, 2020-2035
Table 47: MEA Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 48: MEA Acute Hepatic Porphyria (APH) Market Volume (Units) Forecast by End Use, 2020-2035

List Of Figures

Figure 1: Global Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Application, 2020-2035
Figure 2: Global Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by End Use, 2020-2035
Figure 3: Global Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Region, 2020-2035
Figure 4: Global Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Region, 2020-2035
Figure 5: Global Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Region, 2020-2035
Figure 6: Global Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Region, 2020-2035
Figure 7: Global Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Region, 2020-2035
Figure 8: Global Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 9: Global Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Application, 2020-2035
Figure 10: Global Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 11: Global Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 12: Global Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 13: Global Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by End Use, 2020-2035
Figure 14: Global Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 15: Global Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 16: Global Acute Hepatic Porphyria (APH) Market Attractiveness by Application, 2020-2035
Figure 17: Global Acute Hepatic Porphyria (APH) Market Attractiveness by End Use, 2020-2035
Figure 18: Global Acute Hepatic Porphyria (APH) Market Attractiveness by Region, 2020-2035
Figure 19: North America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Application, 2020-2035
Figure 20: North America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by End Use, 2020-2035
Figure 21: North America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Country, 2020-2035
Figure 22: North America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 23: North America Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Country, 2020-2035
Figure 24: North America Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 25: North America Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 26: North America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 27: North America Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Application, 2020-2035
Figure 28: North America Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 29: North America Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 30: North America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 31: North America Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by End Use, 2020-2035
Figure 32: North America Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 33: North America Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 34: North America Acute Hepatic Porphyria (APH) Market Attractiveness by Application, 2020-2035
Figure 35: North America Acute Hepatic Porphyria (APH) Market Attractiveness by End Use, 2020-2035
Figure 36: North America Acute Hepatic Porphyria (APH) Market Attractiveness by Country, 2020-2035
Figure 37: Latin America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Application, 2020-2035
Figure 38: Latin America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by End Use, 2020-2035
Figure 39: Latin America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Country, 2020-2035
Figure 40: Latin America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 41: Latin America Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Country, 2020-2035
Figure 42: Latin America Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 43: Latin America Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 44: Latin America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 45: Latin America Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Application, 2020-2035
Figure 46: Latin America Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 47: Latin America Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 48: Latin America Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 49: Latin America Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by End Use, 2020-2035
Figure 50: Latin America Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 51: Latin America Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 52: Latin America Acute Hepatic Porphyria (APH) Market Attractiveness by Application, 2020-2035
Figure 53: Latin America Acute Hepatic Porphyria (APH) Market Attractiveness by End Use, 2020-2035
Figure 54: Latin America Acute Hepatic Porphyria (APH) Market Attractiveness by Country, 2020-2035
Figure 55: Europe Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Application, 2020-2035
Figure 56: Europe Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by End Use, 2020-2035
Figure 57: Europe Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Country, 2020-2035
Figure 58: Europe Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 59: Europe Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Country, 2020-2035
Figure 60: Europe Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 61: Europe Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 62: Europe Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 63: Europe Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Application, 2020-2035
Figure 64: Europe Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 65: Europe Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 66: Europe Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 67: Europe Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by End Use, 2020-2035
Figure 68: Europe Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 69: Europe Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 70: Europe Acute Hepatic Porphyria (APH) Market Attractiveness by Application, 2020-2035
Figure 71: Europe Acute Hepatic Porphyria (APH) Market Attractiveness by End Use, 2020-2035
Figure 72: Europe Acute Hepatic Porphyria (APH) Market Attractiveness by Country, 2020-2035
Figure 73: East Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Application, 2020-2035
Figure 74: East Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by End Use, 2020-2035
Figure 75: East Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Country, 2020-2035
Figure 76: East Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 77: East Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Country, 2020-2035
Figure 78: East Asia Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 79: East Asia Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 80: East Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 81: East Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Application, 2020-2035
Figure 82: East Asia Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 83: East Asia Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 84: East Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 85: East Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by End Use, 2020-2035
Figure 86: East Asia Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 87: East Asia Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 88: East Asia Acute Hepatic Porphyria (APH) Market Attractiveness by Application, 2020-2035
Figure 89: East Asia Acute Hepatic Porphyria (APH) Market Attractiveness by End Use, 2020-2035
Figure 90: East Asia Acute Hepatic Porphyria (APH) Market Attractiveness by Country, 2020-2035
Figure 91: South Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Application, 2020-2035
Figure 92: South Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by End Use, 2020-2035
Figure 93: South Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Country, 2020-2035
Figure 94: South Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 95: South Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Country, 2020-2035
Figure 96: South Asia Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 97: South Asia Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 98: South Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 99: South Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Application, 2020-2035
Figure 100: South Asia Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 101: South Asia Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 102: South Asia Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 103: South Asia Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by End Use, 2020-2035
Figure 104: South Asia Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 105: South Asia Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 106: South Asia Acute Hepatic Porphyria (APH) Market Attractiveness by Application, 2020-2035
Figure 107: South Asia Acute Hepatic Porphyria (APH) Market Attractiveness by End Use, 2020-2035
Figure 108: South Asia Acute Hepatic Porphyria (APH) Market Attractiveness by Country, 2020-2035
Figure 109: Oceania Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Application, 2020-2035
Figure 110: Oceania Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by End Use, 2020-2035
Figure 111: Oceania Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Country, 2020-2035
Figure 112: Oceania Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 113: Oceania Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Country, 2020-2035
Figure 114: Oceania Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 115: Oceania Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 116: Oceania Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 117: Oceania Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Application, 2020-2035
Figure 118: Oceania Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 119: Oceania Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 120: Oceania Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 121: Oceania Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by End Use, 2020-2035
Figure 122: Oceania Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 123: Oceania Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 124: Oceania Acute Hepatic Porphyria (APH) Market Attractiveness by Application, 2020-2035
Figure 125: Oceania Acute Hepatic Porphyria (APH) Market Attractiveness by End Use, 2020-2035
Figure 126: Oceania Acute Hepatic Porphyria (APH) Market Attractiveness by Country, 2020-2035
Figure 127: MEA Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Application, 2020-2035
Figure 128: MEA Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by End Use, 2020-2035
Figure 129: MEA Acute Hepatic Porphyria (APH) Market Value (US$ Mn) by Country, 2020-2035
Figure 130: MEA Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 131: MEA Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Country, 2020-2035
Figure 132: MEA Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 133: MEA Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 134: MEA Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 135: MEA Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by Application, 2020-2035
Figure 136: MEA Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 137: MEA Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 138: MEA Acute Hepatic Porphyria (APH) Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 139: MEA Acute Hepatic Porphyria (APH) Market Volume (Units) Analysis by End Use, 2020-2035
Figure 140: MEA Acute Hepatic Porphyria (APH) Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 141: MEA Acute Hepatic Porphyria (APH) Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 142: MEA Acute Hepatic Porphyria (APH) Market Attractiveness by Application, 2020-2035
Figure 143: MEA Acute Hepatic Porphyria (APH) Market Attractiveness by End Use, 2020-2035
Figure 144: MEA Acute Hepatic Porphyria (APH) Market Attractiveness by Country, 2020-2035

- Premium Report Details -

FACT4696MR
Apr-2020
Healthcare
170 Pages
0 Tables
0 Figures

- Let's Connect -

Connect

- Quick Contact -

Chat on Whatsapp

+1 (628) 251-1583

+353-1-4434-232 (D)

+1 (888) 863-5616

sales@factmr.com

- Get Started -

Get insights that lead to new growth opportunities

Buy Now

Get A Special pricing for start-ups and universities

Enquiry Before Buying

- Humble, Yet Honored -

- Research Methodology -

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Schedule a Call